ArticleLeukemia research2010

Paroxysmal nocturnal hemoglobinuria following alemtuzumab immunosuppressive therapy for myelodysplastic syndrome and complicated by recurrent life-threatening thrombosis despite anticoagulation: successful intervention with eculizumab and fondaparinux.

Kit L Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.